Journal of Biopharmaceutical Statistics,volume 23,issue 5  (09-2014)

Period of time： 2014年5期

Publisher： Taylor & Francis Ltd

Founded in： 1991

Total resources： 45

ISSN： 1054-3406

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Journal of Biopharmaceutical Statistics,volume 23,issue 5

Menu

Research Outcomes and Recommendations for the Assessment of Progression in Cancer Clinical Trials

By Bushnell Will,Stone Andrew in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 949-950

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S.,Stone A. M.,Bailey-Iacona R.,Chen T.-T. in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 951-970

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Evaluation of Discordance Measures in Oncology Studies with Blinded Independent Central Review of Progression-Free Survival Using an Observational Error Model

By Mannino F. V.,Amit O.,Lahiri S. in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 971-985

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

A Review of Statistical Issues with Progression-Free Survival as an Interval-Censored Time-to-Event Endpoint

By Sun Xing,Li Xiaoyun,Chen Cong,Song Yang in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 986-1003

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Estimating the Effect of Multiple Imputation on Incomplete Longitudinal Data with Application to a Randomized Clinical Study

By Fong Daniel Y. T.,Rai Shesh N.,Lam Karen S. L. in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 1004-1022

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Bayesian Inference for Skew-Normal Mixture Models With Left-Censoring

By Dagne Getachew A. in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 1023-1041

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

A Note on Partial Covariate-Adjustment and Design Considerations in Noninferiority Trials When Patient-Level Data are not Available

By Nie Lei,Soon Guoxing (Greg),Qi Karen,Chen Yong,Chu Haitao in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 1042-1053

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

A Consistency Approach for Evaluation of Biosimilar Products

By Tsou Hsiao-Hui,Chang Wan-Jung,Hwang Wong-Shian,Lai Yi-Hsuan in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 1054-1066

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Optimal Timing for Interim Analyses in Clinical Trials

By Togo Kanae,Iwasaki Manabu in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 1067-1080

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Randomized Two-Stage Phase II Clinical Trial Designs Based on Barnard's Exact Test

By Shan Guogen,Ma Changxing,Hutson Alan D.,Wilding Gregory E. in (2013)

Journal of Biopharmaceutical Statistics,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-09 , pp. 1081-1090

Taylor & Francis Ltd

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 18 item(s)